Overall rank by patents
#26,415
of 50,000 tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 1 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE).
The verdict
According to USPTO PatentsView, GRS ranks #26,415 of 50,000 tracked US assignees by granted-patent volume, with 10 patents across 1 technology areas.
USPTO PatentsView assignee plate
Corpus R26415 · US Corporation #26,415 · 10 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-LOW · CLAIMS-SPARSE · TYPE-USCORP · VEL-DROP · BOOK-FULL
Nearest grant-volume peer: Gramercy Extremity Orthopedics Llc (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
GRS Guide System · this assignee
18 score
3D Lighting Innovati… · lowest
7 score
What this shows GRS's Innovation Score is 18.3/100 (top 95% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
GRS Guide System, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 40% of grants classified under A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2018. By volume, GRS sits between Gramercy Extremity Orthopedics Llc and Guangzhou EKAI Electronic Technology Co., Ltd..
GRS Guide System, Inc. shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
GRAMERCY EXTREMITY ORTHOPEDICS LLC
10 patents
GRAYHILL, INC.
10 patents
GREENFIELD WORLD TRADE, INC.
10 patents
GROUP-A AUTOSPORTS, INC.
10 patents
GTI Energy
10 patents
GUANGDONG YINGAO KITCHEN UTENSILS CO., LTD.
10 patents
GUANGDONG ZHINENG TECHNOLOGY CO., LTD.
10 patents
GUANGZHOU EKAI ELECTRONIC TECHNOLOGY CO., LTD.
10 patents
GRS Guide System, Inc.
10 patents
What this shows GRS holds 10 patents at rank #26,377, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #26,377 in granted patent volume.
Other assignees with the most granted patents in GRS's primary technology class.
GRS's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
18 Top 95% higher than 5% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 20.0% |
| 2018 | 1 | 10.0% |
| 2019 | 4 | 40.0% |
| 2021 | 1 | 10.0% |
| 2022 | 1 | 10.0% |
| 2023 | 1 | 10.0% |
Top 1 of 1 technology areas
Overall rank by patents
#26,415
of 50,000 tracked assignees
18.3 out of 100
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.